Diseases · Entity Annotation Prototype (beta)

1articles mentioning diseases

1disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: Met-ALD ×

Met-ALD

This disease is selected. Its supporting articles are shown below.

Met-ALD1

Articles mentioning Met-ALD

1 articles · page 1 of 1

P68 An open-label phase 1/2 multicentre study to evaluate the safety, tolerability and efficacy of RTX001 autologous macrophages in participants with liver cirrhosis who have hepatic decompensation (EMERALD)

gutjnl · abstract · 2025-10-06 · 1 matching annotations

82.2%

hepatocellular carcinoma cirrhosis ALD MASLD Met-ALD steatotic liver disease G-CSF EMERALD

… a baseline MELD 3.0 score of 12–20. Exclusion criteria include hepatocellular carcinoma, portal vein thrombosis, significant hydrothorax, splenomegaly …

Browse diseases

Met-ALD

Articles mentioning Met-ALD

P68 An open-label phase 1/2 multicentre study to evaluate the safety, tolerability and efficacy of RTX001 autologous macrophages in participants with liver cirrhosis who have hepatic decompensation (EMERALD)